4//SEC Filing
Crowley Elizabeth 4
Accession 0001179110-21-010819
CIK 0000744218other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:02 PM ET
Size
9.0 KB
Accession
0001179110-21-010819
Insider Transaction Report
Form 4
Crowley Elizabeth
SR. VP & CPDO
Transactions
- Sale
Common Stock
2021-12-08$40.00/sh−4,000$160,000→ 4,726 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2021-12-08−4,000→ 16,000 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (4,000 underlying) - Exercise/Conversion
Common Stock
2021-12-08$9.02/sh+4,000$36,066→ 8,726 total
Footnotes (3)
- [F1]On February 8, 2019, Celldex Therapeutics, Inc. effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). This option was previously reported as covering 300,000 shares at an exercise price of $0.6011 per share, but has been adjusted to reflect the Reverse Stock Split.
- [F2]The sale of the shares of Common Stock were made pursuant to a plan intended to comply with Rule 10b5-1 of the Exchange Act, previously entered into on September 15, 2021.
- [F3]25% vested on June 13, 2019 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001681854
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:02 PM ET
- Size
- 9.0 KB